Designation: Senior Research Associate (9-II)
Job Location: Bangalore
Department: BBRC - PCO
Educational Qualifications: M. Pharm or M.S. (Pharm.)
Experience: 0-2 years
Responsibilities:
An ideal candidate will independently execute in-vivo rodent pharmacokinetic (PK) studies in support of drug discovery in a fast-paced environment. This role requires a good understanding of PK parameters and related PK software (e.g. Phoenix WinNonlin) and pharmacology. The candidate will be responsible for conducting studies, sample handling, PK data analysis and interpretation of results. Work collaboratively with formulation, bioanalytical and biology scientists to plan and complete assigned studies. Participate in project team meetings. Good interpersonal skills, and ability to work effectively in a team environment.
Requirements :
The candidate must possess experience in animal handling, conducting studies, sample handling, PK data analysis and interpretation of results. Jugular vein cannulation and any other surgical skill will be desirable. He / She should have interest in learning, good problem solving, and good communication skills.
Strong commitment toward work and a high level of dedication, enthusiasm, and motivation
Good speaking-listening-writing skills, attention to detail, proactive self-starter
Ability to work successfully in a dynamic environment
Ability to meet tight deadlines and prioritize workloads.
Persuasive ability in a team and cross-functional environment
Ability to develop new ideas and creative solutions
Syngene is a contract research, development, and manufacturing organization (CRDMO) that offers integrated manufacturing, research, and development services to firms in the agrochemical, biotechnology, pharmaceutical, and animal healthcare sectors. World industry leaders comprise Syngene's clientele, including small and medium-sized start-ups, government agencies, non-profits, and academic institutions.
Listed separately on the NSE and BSE Indian stock exchanges, Syngene was founded in 1993. Syngene works for clients worldwide, producing innovation that improves human and animal health. The company has a distinctive business strategy, a talent pool of over 6000 scientists, scientific knowledge across novel therapeutic modalities, an experienced management team, and an independent Board committee. Syngene serves as a strategic partner to its clients, frequently functioning as an extension of their internal scientific teams, and provides creative, adaptable, and effective methods for quickly scaling up. Faster access to patients and go-to-market are thus made possible by this.
Syngene is adamant about striking a balance between corporate expansion and environmental responsibility. The four main pillars of its ecological, social, and governance (ESG) strategy are controlling its environmental impact, upholding solid governance, investing in local communities, and being a responsible employer. According to this plan, Syngene recycled 20% of its water, 86% of its energy came from renewable sources, and it saved 1.99 million KWh of energy through operational efficiency. It also recycled 92% of its hazardous and non-hazardous trash (see the ESG report).